Stromal tumor-infiltrating lymphocytes evaluated on H&E-stained slides are an independent prognostic factor in epithelial ovarian cancer and ovarian serous carcinoma

被引:21
|
作者
Hwang, Chungsu [1 ,2 ]
Lee, So Jung [3 ]
Lee, Jung Hee [1 ,2 ]
Kim, Ki Hyung [4 ]
Suh, Dong Soo [4 ]
Kwon, Byung-Su [4 ]
Choi, Kyung Un [3 ]
机构
[1] Pusan Natl Univ, Yangsan Hosp, Dept Pathol, Yangsan 50612, Gyeongsangnam D, South Korea
[2] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan 50612, Gyeongsangnam D, South Korea
[3] Pusan Natl Univ Hosp, Dept Pathol, Busan 602739, South Korea
[4] Pusan Natl Univ Hosp, Dept Obstet & Gynecol, Busan 602739, South Korea
关键词
ovarian cancer; tumor-infiltrating lymphocyte; survival; hematoxylin; eosin; BREAST-CANCER; T-CELLS; CHEMOTHERAPY; SURVIVAL; TILS;
D O I
10.3892/ol.2019.10095
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Studies on tumor-infiltrating lymphocytes (TILs) in epithelial ovarian cancer (EOC) have focused on the clinical significance of inflammatory cells of specific subtypes that are identifiable using immunohistochemistry. However, the subtypes of inflammatory cells that reportedly affect patient survival and prognosis have differed from study to study, and few studies have examined TILs using hematoxylin and eosin (H&E) staining. Therefore, the present study aimed to identify the clinical importance of general stromal TILs in EOC by using H&E staining to apply breast cancer recommendations from the International TILs Working Group 2014 on breast cancer using H&E staining. Stromal TILs in 256 EOC cases from Pusan National University Hospital and 475 cases of high-grade serous carcinoma from The Cancer Genome Atlas dataset were assessed. Stromal TILs were evaluated using H&E-stained slides according to the breast cancer recommendations of the International Working Group 2014, and patients were classified into low and high stromal TIL groups according to their stromal TIL values. The associations of these groups with clinicopathologic factors were assessed, and it was confirmed that group membership correlated with survival and prognosis. According to the (2) assessment, the stromal TIL group was associated with tumor grade. Furthermore, the stromal TIL group was associated with overall survival according to Kaplan-Meier analysis with the log-rank test. Finally, the stromal TIL group was an independent prognostic factor according to univariate and multivariate Cox regression analyses. In cases of EOC, the evaluation of general stromal TILs on H&E-stained slides could be used to predict prognosis.
引用
收藏
页码:4557 / 4565
页数:9
相关论文
共 44 条
  • [21] Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)
    Farrag, Mayada Saad
    Abdelwahab, Khaled
    Farrag, Nesrine Saad
    Elrefaie, Waleed Elsayed
    Emarah, Ziad
    JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE, 2021, 33 (01)
  • [22] Prognostic role of different PD-L1 expression patterns and tumor-infiltrating lymphocytes in high-grade serous ovarian cancer: a systematic review and meta-analysis
    Wang, Ye-Min
    Cai, Wei
    Xue, Qing-Ming
    Zhang, Jin-Yao
    Zhou, Lv
    Xiong, Su-Yi
    Deng, Huan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [23] Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancer
    Zhou, Guangrun
    Zheng, Jifang
    Chen, Zhiwei
    Hu, Dan
    Li, Suyu
    Zhuang, Wu
    He, Zhiyong
    Lin, Gen
    Wu, Biao
    Zhang, Wei
    Fang, Weimin
    Zheng, Fei
    Wang, Jiezhong
    Chen, Gang
    Chen, Mingqiu
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [24] Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
    Ninke Leffers
    Marloes J. M. Gooden
    Renske A. de Jong
    Baukje-Nynke Hoogeboom
    Klaske A. ten Hoor
    Harry Hollema
    H. Marieke Boezen
    Ate G. J. van der Zee
    Toos Daemen
    Hans W. Nijman
    Cancer Immunology, Immunotherapy, 2009, 58
  • [25] Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinoma
    Kyung Un Choi
    Ahrong Kim
    Jee Yeon Kim
    Ki Hyung Kim
    Chungsu Hwang
    So Jung Lee
    Won Young Park
    Sejin Jung
    Hye Jeong Choi
    Kyungbin Kim
    Journal of Ovarian Research, 13
  • [26] Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinoma
    Choi, Kyung Un
    Kim, Ahrong
    Kim, Jee Yeon
    Kim, Ki Hyung
    Hwang, Chungsu
    Lee, So Jung
    Park, Won Young
    Jung, Sejin
    Choi, Hye Jeong
    Kim, Kyungbin
    JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
  • [27] A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections
    Iseki, Yasuhito
    Shibutani, Masatsune
    Maeda, Kiyoshi
    Nagahara, Hisashi
    Fukuoka, Tatsunari
    Matsutani, Shinji
    Kashiwagi, Shinichiro
    Tanaka, Hiroaki
    Hirakawa, Kosei
    Ohira, Masaichi
    PLOS ONE, 2018, 13 (04):
  • [28] Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
    Goode, Ellen L.
    Block, Matthew S.
    Kalli, Kimberly R.
    Vierkant, Robert A.
    Chen, Wenqian
    Fogarty, Zachary C.
    Gentry-Maharaj, Aleksandra
    Toloczko, Aleksandra
    Hein, Alexander
    Bouligny, Aliecia L.
    Jensen, Allan
    Osorio, Ana
    Hartkopf, Andreas D.
    Ryan, Andy
    Chudecka-Glaz, Anita
    Magliocco, Anthony M.
    Hartmann, Arndt
    Jung, Audrey Y.
    Gao, Bo
    Hernandez, Brenda Y.
    Fridley, Brooke L.
    McCauley, Bryan M.
    Kennedy, Catherine J.
    Wang, Chen
    Karpinskyj, Chloe
    de Sousa, Christiani B.
    Tiezzi, Daniel G.
    Wachter, David L.
    Herpel, Esther
    Taran, Florin Andrei
    Modugno, Francesmary
    Nelson, Gregg
    Lubinski, Jan
    Menkiszak, Janusz
    Alsop, Jennifer
    Lester, Jenny
    Garcia-Donas, Jesus
    Nation, Jill
    Hung, Jillian
    Palacios, Jose
    Rothstein, Joseph H.
    Kelley, Joseph L.
    de Andrade, Jurandyr M.
    Robles-Diaz, Luis
    Intermaggio, Maria P.
    Widschwendter, Martin
    Beckmann, Matthias W.
    Ruebner, Matthias
    Jimenez-Linan, Mercedes
    Singh, Naveena
    JAMA ONCOLOGY, 2017, 3 (12)
  • [29] The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
    Pizarro, David
    Romero, Ignacio
    Perez-Mies, Belen
    Redondo, Andres
    Caniego-Casas, Tamara
    Carretero-Barrio, Irene
    Cristobal, Eva
    Gutierrez-Pecharroman, Ana
    Santaballa, Ana
    D'Angelo, Emanuela
    Hardisson, David
    Vieites, Begona
    Matias-Guiu, Xavier
    Estevez, Purificacion
    Guerra, Eva
    Prat, Jaime
    Poveda, Andres
    Lopez-Guerrero, Jose Antonio
    Palacios, Jose
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
  • [30] Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)
    Mayada Saad Farrag
    Khaled Abdelwahab
    Nesrine Saad Farrag
    Waleed Elsayed Elrefaie
    Ziad Emarah
    Journal of the Egyptian National Cancer Institute, 33